Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

CELULARITY INC (CELU)

  • Technical Exchange News
  • April 25, 2026, 01:55 UTC
  • 4
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

CELULARITY INC (CELUW)

  • Technical Exchange News
  • April 25, 2026, 01:55 UTC
  • 4
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Delinquent.

Comment Full text

YHNAU attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

YHNAU attributes changed: Attr: Fin_status N -> D;

Comment Full text

YHNA attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

YHNA attributes changed: Attr: Fin_status N -> D;

Comment Full text

YHNAR attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

YHNAR attributes changed: Attr: Fin_status N -> D;

Comment Full text

VIVOS THERAPEUTICS, INC. (VVOS)

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

VVOS attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

VVOS attributes changed: Attr: Fin_status N -> D;

Comment Full text

VRME attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

VRME attributes changed: Attr: Fin_status N -> D;

Comment Full text

SEGG attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:52 UTC
  • 4
  • 0 comments

SEGG attributes changed: Attr: Fin_status N -> E;

Comment Full text

MIGI attributes changed

  • Technical Exchange News
  • April 25, 2026, 01:51 UTC
  • 2
  • 0 comments

MIGI attributes changed: Attr: Fin_status N -> D;

Comment Full text
  • Previous
  • 15
  • 16
  • 17
  • 18
  • 19
  • Next

Search

News categories

  • Technical Exchange News(12213)
  • Event(6113)
  • SEC News(262561)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(153935)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin